CHMP reiterates negative opinion on XBiotech's Hutruo

EMA's CHMP reiterated its May negative opinion regarding an MAA from XBiotech Inc. (NASDAQ:XBIT) for Hutruo (Xilonix, CV-18C3, T2-18C3, RA-18C3, MABp1, CA-18C3) to treat symptoms of advanced colorect...